| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.39 | 0.06 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |